INTRODUCTION
Choroideremia is an X-linked eye disorder characterized by progressive dystrophy of the choroid, retinal pigment epithelium and retina (1, 2) . Affected males develop night blindness in early adulthood, which is followed by a progressive constriction of the visual fields. Eventually, complete blindness occurs by the fourth to fifth decade of life. Using positional cloning strategies, Cremers et al. (3) and Merry et al. (4) isolated part of the candidate gene for choroideremia. The gene, designated CHM, is expressed in various tissue types, including retina and choroid and/or retinal pigment epithelium (3; F.P.M.C. unpublished data). The open reading frame (ORF) of the CHM gene was found to be disrupted in 10 male patients with deletions and in a female patient carrying a balanced X; 13 translocation involving the Xq21.2 band (3, (5) (6) (7) . Convincing evidence that the CHM gene is underlying choroideremia has been provided by the identification of several point mutations in the 3' part of the CHM ORF in patients with classical choroideremia (8) (9) (10) (11) .
Recently, an autosomal homologue of the CHM gene has been isolated, which was designated CHML (choroideremia-like) (12) . The CHML gene is located in the distal part of chromosome lq (Iq42-qter), in the vicinity of a gene locus for Usher syndrome type II, an autosomal recessive form of retinal degeneration in conjunction with hearing loss. Patients suffering from Usher syndrome type II however, do not show mutations in the ORF of the CHML gene which renders the CHML gene an unlikely candidate for USHTJ (13) .
The function of the CHM gene product was elucidated through the isolation of the protein Rab geranylgeranyl transferase (Rab GGTase) from rat brain, which consist of 3 subunits (14) . An a-and /3-subunit constitute the catalytic part of this enzyme; the CHM protein acts as an indispensable stimulator of geranylgeranylation. By using recombinant rat CHM protein produced in insect cells, Andres et al. (15) showed that the CHM protein also functions as a Rab escort protein (REP-1), before and after attachment of the geranylgeranyl group onto Rab protein. Lymphoblasts of choroideremia patients have a markedly decreased, but still detectable, Rab GGTase activity (16) . The residua] activity in lymphoblasts of these patients might be attributed to the functional compensation of the CHML protein (REP-2) (17) . From here on we will only use the designations CHM and CHML.
Comparison of the predicted amino acid sequence of the human CHM protein with the amino acid sequences of rat CHM, mouse CHM and human CHML indicated that the cloned CHM cDNA sequence lacked approximately 50% of the coding sequence at its 5' end. We now report the cloning of the complete cDNA sequence of the human CHM gene. Elucidation of its exon-intron structure has enabled us to refine the the localization of the X-chromosomal breakpoint in a female patient with a balanced X-autosome translocation.
CHM cDNA (p622). The complete open reading frame of the mouse CHM gene has been cloned and shows 87% sequence homology to the previously published ORF of the human CHM cDNA sequence (3,4,12; I.Bach, unpublished results). Eight recombinant phages were identified, which were further analyzed by hybridization to human CHML cDNA (p643) and p622. The human CHM and CHML cDNA sequences are 79% homologous. Thus, the intensity of the hybridization signal with p622 and p643 is a rough indication of whether the recombinant phages contain CHM or CHML sequences. One clone, FB25, was isolated containing sequences that are highly homologous to the 5' end of the mouse CHM cDNA but only moderately homologous to the human CHML sequence. However, since no overlapping sequences were found with known sequences from the human CHM gene (clone T120; Fig. 1 ), it could not be concluded which, if any, of the FB25 sequences were derived from the CHM gene. To clarify this uncertainty, we made use of the reverse transcriptase-polymerase chain reaction (RT-PCR) employing a sense primer (658) that hybridizes to clone FB25 as well as an antisense primer (559) specific for nucleotides 833 to 852 of the human CHM gene (Fig. 2) . Direct sequencing of the resulting PCR product (RT 1; Fig. 1 ) confirmed that FB25 contains previously unidentified sequences from the 5' end of the CHM gene.
Sequence comparison with known CHM cDNAs revealed that FB25 did not encompass the complete 5' end of the CHM gene. Therefore, the 720 bp insert of FB25 was used to screen 7.5 x 10 5 phage recombinants of a human retinal cDNA library. Only one positive clone was detected (Rl; Fig. 1 ), which harbours an insert of 1085 bp and starts with the G of the presumptive ATG start codon, as based on sequence homology with known CHM cDNAs of rat and mouse. Clone Rl completely matches the sequences contained in clones FB25 and RT1 as well as the 5' end of clone T120.
The partly overlapping human CHM cDNA clones span 5.45 kb. The consensus cDNA contains an ORF encoding a protein of 653 amino acids (Fig. 2) . The deduced amino acid sequence of the CHM protein shows 72% and 84% identity with the predicted sequences of the human CHML and mouse CHM protein, respectively. The amino acid similarities of the CHM protein with the CHML and mouse CHM proteins are 81 % and 89%, respectively, as determined with the BESTFTT program (18) . The large degree of homology of the predicted CHM protein with the mouse and rat CHM proteins indicates that we have now isolated the entire CHM cDNA sequence, except for the 5' noncoding region and the AT of the start codon. Thus, we have extended the previously reported CHM sequences by 863 nucleotides towards the 5' end (3, 4) . The only discrepancy between this sequence and the one published previously by blot analysis with different parts of the CHM cDNA as probes (data not shown). Upon digestion of YAC DNA with either £coRI or Xbal, shotgun libraries were created in XZAPII. Plaque lifts were probed employing the relevant CHM cDNA restriction fragments. Positive phage recombinants were purified to homogeneity and inserts were transferred to plasmid Bluescript by in vivo excision. In most cases, the EcoRI or Xbal inserts were subcloned by making use of frequently cutting enzymes, in order to facilitate sequencing of the exons and the flanking intron sequences using pBluescript vector primers. The exact intron-exon boundaries were inferred upon comparison of genomic sequences with cDNA sequences (Table 1 and Fig. 1) . A total of 15 exons were identified, ranging in size from 63 nucleotides for exon 11 to 3.4 kb for exon 15. To avoid confusion, we have replaced the previous alphabetical designations of the exons by arabic numerals. Thus, exons 1 to 5 contain the novel sequences presented in this paper, while exons 6 to 15 substitute the former exons Al to E. The match between the identified splice acceptor and donor sites and the respective consensus sequences was calculated using the formulae described by Shapiro and Senapathy (19) ( Table 1) .
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Comparison of the sequence of exon 1 with the 5' end of the cDNA sequence revealed that an ATG codon is indeed present at the position depicted in Fig. 2 . The first 24 nucleotides upstream of the CHM start codon in exon 1 deviate at only one position from the respective nucleotides of the mouse CHM cDNA sequence. Immediately downstream of this homologous sequence are two stop codons, which are in the same reading frame as the proposed start codon. The stop codons (TAA and TAG) are preceeded by a sequence that matches very well the consensus sequence of a splice acceptor site. Taken together, these results strongly indicate that the sequence given in Fig. 1 represents the complete ORF of the CHM gene as well as some of the 5' and 3' non-coding sequences. This sequence, together with the complete 3' non-coding region up to the poly (A) tail, constitutes a 5.45 kb consensus CHM cDNA sequence. The size of the corresponding mRNA is approximately 5.6 kb, indicating that we may still lack some of the 5' non-coding sequences.
Characterization of a translocation breakpoint associated with choroideremia
In a female with choroideremia and a t(X; 13) translocation, the X-chromosomal breakpoint was mapped to intron 12 of die CHM gene (3). In another affected female, TDo, who suffers from choroideremia and gonadal dysgenesis, the t(X;7) translocation breakpoint had been located previously between probes pZll (DXS540) and pXG7c (DXS95) (20) . To refine the localization of the TDo breakpoint, a Southern blot analysis was performed using p759 (FB25), a cDNA clone spanning exons 2 to 5 from the CHM gene (Fig. 3) . It appeared that a hybrid cell line with (19) . The given splice acceptor site of exon 1 is 4 nucleotides downstream to the point where the sequence homology between mouse CHM cDNA and human genomic DNA (exon 1) suddenly stops. the derf7) as the sole human X-chromosomal component contains exon 2, while exon 5 is missing, which clearly demonstrates that the translocation breakpoint is located within the CHM gene. The 15 kb EcoKl fragment containing exons 3 and 4 was altered and migrated as a 12.5 kb fragment in the hybrid cell line of TDo. However, it could not be determined from the Southern blot whether the der(7) harbours exons 3 and 4, or only exon 3. To resolve this question, we employed a PCR analysis, which revealed that exon 3 is present and exon 4 is absent on the der(7) (data not shown). Hence, the TDo breakpoint within the CHM gene is either located in intron 3 or in exon 4.
DISCUSSION
We have isolated and characterized the cDNA sequence of the CHM gene and resolved its intron-exon structure. The CHM gene is composed of 15 exons, which span at least 150 kb of Xq21.2. The identification of the additional 5' sequences of the CHM gene allowed us to determine the t(X;7) translocation breakpoint in a female with choroideremia. As in the female with a balanced t(X;13) translocation studied previously (3), the breakpoint was found to be located within the CHM gene, providing further evidence that the CHM gene is the sole gene in the Xq21 region that is involved in choroideremia. The ORF of the CHM gene encodes a protein of 653 amino acids, the sequence of which is highly homologous to the predicted mouse CHM protein, the rat CHM protein and, to a slightly lesser extent, the human CHML protein.
The size of the isolated CHM cDNA sequence (5.45 kb) is close to the size of the transcript seen on Northern blots (3; F.P.M.C. unpublished data), but it is possible that we are still lacking nucleotides from the 5' non-coding region of the gene. The existence of an exon that preceeds exon 1 is suggested by the presence of a splice acceptor site at the position where the homology between the human genomic DNA sequence and the mouse cDNA sequence suddenly stops. If there is indeed an additional exon at the 5' end of the gene, its isolation will be necessary for the identification of CHM promoter sequences.
It is noteworthy that exon 9 was very difficult to isolate from the XZAPII shotgun libraries of YAC B231, as positive plaques were repeatedly lost during purification. When exon 9 was cloned as a 6 kb Xbal fragment, an unusual repeat sequence was detected close to the splice donor site of exon 9. The highly polymorphic repeat sequence (van Bokhoven et al., in preparation) consists of 20 to 40 units of (AT) 4 _ 12 C. In YAC B231, the (AT) 4 _ 12 C motif is repeated 20 times and has a size of approximately 300 bp. In contrast, the corresponding Xbal subclone of YAC B231 contains only 5 repeat units with a total size of 90 bp. The discrepancy between the size of the repeat in YAC B231 and its Xbal subclone is most likely caused by loss of most of the repeat sequence in XZAPEI or plasmid Bluescript. Thus, phages containing the repeat may not be replicated efficiently in E.coli. Given the close proximity of the repeat sequences to exon 9, this would well explain our difficulties in isolating a faithful copy of exon 9 and its flanking repeat.
The 15 identified exons of the CHM gene span a genomic sequence of at least 150 kb, which means that the average intron length is about 10 kb. This differs markedly from the average intron length of 1.1 kb that has been determined for other vertebrate genes (21) . The functional significance of the occurrence of such large introns in the CHM gene is not clear. It has been demonstrated that large introns are sometimes involved in the regulation of transcription or may control the splicing reactions of pre-mRNAs (21, 22) . In this context, the absence of introns in the closely related CHML gene is very interesting (12) . The CHM and CHML proteins perform similar functions as subunits of Rab GGTases and, in choroideremia patients, loss of CHM activity seems to be masked by the compensatory activity of the CHML protein in most tissues (17) . The apparent insufficient compensation in the eye of these patients may well be explained by the differential expression of these two genes in the eye. Now that we have isolated the CHM gene and have determined the exon composition of the gene, it should be possible to identify the regulatory signals of its expression and search for differences with the CHML gene.
Our studies have paved the way to-and in fact were initiated because of the prospects for-mutation detection in choroideremia patients. In sporadic cases of choroideremia, rapid mutation analysis can be performed by PCR-mediated amplification of exons followed by direct sequencing. In addition, our studies have identified two highly polymorphic microsatellite markers from within the CHM gene (23, van Bokhoven et al., manuscript in preparation), which should be very valuable for diagnostic studies in choroideremia families.
MATERIALS AND METHODS
CHM patients and cell lines
The diagnostic criteria of choroideremia included a history of night blindness and the appearance of the fundus, showing peripheral pigmentary retinopathy with areas of pigmented epithelial and choroida] atrophy. Two females showing signs of choroideremia were karyotyped as 46,X,t(X;13)(q21.2;pl2) and 46,X,t(X;7)(q21;pl2) (patient TDo) by Siu et al. (24) and Kaplan et al. (25) , respectively. A female (WD) with a 46,X,t(X;2)(q21;p25) had primary amenorrhoea, but did not show any clinical signs characteristic of choroideremia. Physical mapping of the translocation breakpoints has been carried out previously (20, 26) . Human-rodent cell hybrids were obtained for TDo and WD. GMO6318B is a human-hamster hybrid, which contains the human X chromosome as the only chromosome of human origin. Odier lymphoblastoid cell lines were established from peripheral blood using Epstein-Barr virus. HER XC2 is a human embryonal retinal cell line (27) .
Southern Mot analysis
Chromosomal DNA was isolated essentially according to a method described elsewhere (28) . DNA (10 /ig) was digested with EcoVl and fragments were resolved by electrophoresis in a 1 % agarose gel and blotted onto GeneScreen Plus membranes (New England Nuclear). 32 P-labeled probes were prepared by random hexamer priming (29, 30) on the appropriate DNA fragments that were isolated in low-gelling temperature agarose (Biolabs). Prehybridization and hybridization were performed as described previously (31) , at a temperature of 65°C. Washing was done at the same temperature in 40 raM sodium phosphate (pH 7.2) and 1% (w/v) sodium dodecyl sulphate (SDS).
Screening of cDNA libraries
For the isolation of CHM cDNA sequences we employed a random-primed XZAPII human fetal brain cDNA library (Stratagene) and an oligo d(T)-and randomprimed XgtlO '5' stretch' human retina cDNA library (Clontech). Approximately 5X10 5 phage recombinants from the fetal brain library comprising 2x10°i ndependent clones, were plated on the bacterial host XL-Blue. Plaques were lifted onto Nitrocellulose filters (Schleicher and Schuell, BA85), using standard procedures (32) . The filters were prehybridized at 50°C for 6 h in 6xSSC, 0.1 % (w/v) Ficoll, 0.1 % (w/v) polyvinylpyrrolidone, 0.1 % BSA, 10% (w/v) dextrane sulphate, 0.2% (w/v) SDS, and 250 /ig sonicated and denatured herring sperm DNA per ml. Hybridization was performed for 16 h at 50°C in die same solution, including 3 ng/ml (5x 10 s cpm 52 P/^g) of mouse CHM cDNA probe. Positive XZAPII plaques were purified and transformed to plasmid clones using the Stratagene excision protocol. Approximately 7.5 x 10 5 phage recombinants from the retina library comprising 1.6x 10 s independent clones, were plated on the bacterial host C600HQ. Screening was as described for the fetal brain library, except that hybridization was at 65°C, using a probe from the 5' end of the CHM gene. Phage DNA was isolated for positive XgtlO clones, using die Qiagen lambda kit. Inserts were excised with EcoRI and cloned into plasmid Bluescript (Stratagene).
Construction of genomk DNA libraries YAC clone B231 was identified by amplification of exon 13 with primers 464 and 478 (8) . Yeast cell culturing and DNA isolation was performed as described elsewhere (33) . YAC DNA was digested with either EcoRI or Xbal (Life Technologies) and DNA fragments were extracted with phenol/chloroform and precipitated with ethanol. 300 ng of the £coRI and Xbal fragments was ligated to 1 /ig of XZAPII DNA, diat was digested with EcoRI and Xbal, respectively. Phage DNA was packaged using the Packagene packaging extract (Promega). A total of 50,000 phages of each library were screened as described above, using probes derived from the human CHM or mouse CHM cDNAs.
RNA isolation and cDNA synthesis
Total RNA was isolated from HER XC2 cells by the modified UQ-ura procedure (34, 35) . cDNA synthesis was performed in a 10 ^1 reaction volume containing 125 ng total RNA, 50 ng random hexamer primers (Pharmacia), 10 mM Tris, 50 mM KC1, 5 mM MgCl 2 , 0.01% (w/v) gelatin, 1 mM dNTPs, 27 units RNasin (Pharmacia) and 0.5 units MMLV-RT (Life Technologies). Incubation was for 10 min at room temperature, 60 min at 37°C and 6 min at 99°C.
CHM cDNA products were PCR-amplified with sense primer 658 (5'-GCATG-AAGATGTCGAAC-3') and antisense primer 559 (5'-ACGGAACCTGTTCC-ACTCGT-3'). PCR amplification was performed in a 50 ^1 reaction volume 125 ng of each primer, 10 mM Tris, 50 mM KC1, 1.5 mM MgCl 2 , 0.01% (w/v) gelatin, 0.2 mM dNTPs and 2.5 units amplitaq (Perkin Elmer). 40 cycles of denaturation at 95°C for 1 min, annealing at 54°C for 1 min and extension at 72°C for 1.5 min were carried out with an initial denaturation step of 5 min and a final extension step of 10 min. The PCR products were analysed on a 1.5% agarose gel.
DNA sequencing
Sequencing of inserts of CHM positive cDNA clones was performed on doublestranded pBluescript DNA employing the T3, T7, KS and SK primers in conjunction with the Pharmacia T7 sequencing kit.
For sequencing of the RT-PCR fragments the PCR amplification reaction mixtures were diluted 1:50 wim H 2 O (approximately 2 ng PCR product per /jl) and direct sequencing was performed on 9 /J diluted PCR produa using die cycle sequencing protocol (36) .
